Literature DB >> 35121836

Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer.

Francisco Martínez-Jiménez1, Ferran Muiños1, Erika López-Arribillaga1, Nuria Lopez-Bigas2,3,4, Abel Gonzalez-Perez5,6.   

Abstract

E3 ligases and degrons, the sequences they recognize in target proteins, are key parts of the ubiquitin-mediated proteolysis system. There are several examples of alterations of these two components of the system that have a role in cancer. Here we uncover the landscape of the contribution of such alterations to tumorigenesis across cancer types. We first systematically identified new instances of degrons across the human proteome by using a random forest classifier and validated the functionality of a dozen of them, exploiting somatic mutations across >7,000 tumors. We detected signals of positive selection across known and new degron instances. Our results reveal that several oncogenes are frequently targeted by mutations that affect the sequence of their degrons or their cognate E3 ubiquitin ligases, causing an abnormal increase in their protein abundance. Overall, an important number of driver mutations across primary tumors affect either degrons or E3-ubiquitin ligases.
© 2019. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 35121836     DOI: 10.1038/s43018-019-0001-2

Source DB:  PubMed          Journal:  Nat Cancer        ISSN: 2662-1347


  55 in total

1.  Distinct functions of the ubiquitin-proteasome pathway influence nucleotide excision repair.

Authors:  Thomas G Gillette; Shirong Yu; Zheng Zhou; Raymond Waters; Stephen Albert Johnston; Simon H Reed
Journal:  EMBO J       Date:  2006-06-07       Impact factor: 11.598

Review 2.  On the Dependency of Cellular Protein Levels on mRNA Abundance.

Authors:  Yansheng Liu; Andreas Beyer; Ruedi Aebersold
Journal:  Cell       Date:  2016-04-21       Impact factor: 41.582

3.  ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation.

Authors:  A Ciechanover; H Heller; S Elias; A L Haas; A Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

4.  Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis.

Authors:  A Hershko; A Ciechanover; H Heller; A L Haas; I A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

Review 5.  Degrons in cancer.

Authors:  Bálint Mészáros; Manjeet Kumar; Toby J Gibson; Bora Uyar; Zsuzsanna Dosztányi
Journal:  Sci Signal       Date:  2017-03-14       Impact factor: 8.192

6.  Proteasome inhibition rescues clinically significant unstable variants of the mismatch repair protein Msh2.

Authors:  Tim Arlow; Kristan Scott; Aubrey Wagenseller; Alison Gammie
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

Review 7.  The ubiquitous role of ubiquitin in the DNA damage response.

Authors:  Abdallah Al-Hakim; Cristina Escribano-Diaz; Marie-Claude Landry; Lara O'Donnell; Stephanie Panier; Rachel K Szilard; Daniel Durocher
Journal:  DNA Repair (Amst)       Date:  2010-11-04

8.  Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm.

Authors:  Seung-Hee Yoo; Jennifer A Mohawk; Sandra M Siepka; Yongli Shan; Seong Kwon Huh; Hee-Kyung Hong; Izabela Kornblum; Vivek Kumar; Nobuya Koike; Ming Xu; Justin Nussbaum; Xinran Liu; Zheng Chen; Zhijian J Chen; Carla B Green; Joseph S Takahashi
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

Review 9.  E2 enzymes: more than just middle men.

Authors:  Mikaela D Stewart; Tobias Ritterhoff; Rachel E Klevit; Peter S Brzovic
Journal:  Cell Res       Date:  2016-03-22       Impact factor: 25.617

10.  Tripartite degrons confer diversity and specificity on regulated protein degradation in the ubiquitin-proteasome system.

Authors:  Mainak Guharoy; Pallab Bhowmick; Mohamed Sallam; Peter Tompa
Journal:  Nat Commun       Date:  2016-01-06       Impact factor: 14.919

View more
  6 in total

Review 1.  The roles of E3 ligases in Hepatocellular carcinoma.

Authors:  Zongdong Yu; Hong Li; Jie Zhu; Haibiao Wang; Xiaofeng Jin
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools.

Authors:  Carlos A Garcia-Prieto; Francisco Martínez-Jiménez; Alfonso Valencia; Eduard Porta-Pardo
Journal:  Bioinformatics       Date:  2022-05-05       Impact factor: 6.931

3.  Systematic characterization of mutations altering protein degradation in human cancers.

Authors:  Collin Tokheim; Xiaoqing Wang; Richard T Timms; Boning Zhang; Elijah L Mena; Binbin Wang; Cynthia Chen; Jun Ge; Jun Chu; Wubing Zhang; Stephen J Elledge; Myles Brown; X Shirley Liu
Journal:  Mol Cell       Date:  2021-02-09       Impact factor: 19.328

4.  An Integrated Analysis of the Identified PRPF19 as an Onco-immunological Biomarker Encompassing the Tumor Microenvironment, Disease Progression, and Prognoses in Hepatocellular Carcinoma.

Authors:  Ming Yang; Yiwen Qiu; Yi Yang; Wentao Wang
Journal:  Front Cell Dev Biol       Date:  2022-02-17

5.  Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning.

Authors:  Chao Hou; Yuxuan Li; Mengyao Wang; Hong Wu; Tingting Li
Journal:  BMC Biol       Date:  2022-07-14       Impact factor: 7.364

6.  Discovering the drivers of clonal hematopoiesis.

Authors:  Oriol Pich; Iker Reyes-Salazar; Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nat Commun       Date:  2022-07-23       Impact factor: 17.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.